Management of Diabetic Keto-Acidosis in Critically ill Patients

CASE DISCUSSION

Management of Diabetic Keto-Acidosis in Critically ill Patients

Presented from by Dr. Prof. Mathieu Jozwaik

0

Likes

8139

Views

326

Shares

0

Bookmarks

Case Description

Management of DKA in critically ill patients requires rapid recognition, hemodynamic stabilization, and correction of metabolic derangements. Initial treatment includes aggressive fluid resuscitation with isotonic saline to restore perfusion, followed by insulin infusion to suppress ketogenesis and...

Case Summary

  • Diabetic ketoacidosis (DKA) is defined by hyperglycemia, ketosis (blood or urine), and metabolic acidosis. It must be differentiated from hyperglycemic hyperosmolar state (HHS), which involves hyperglycemia and hyperosmolarity but lacks significant ketosis or acidosis. DKA severity is stratified as mild, moderate, or severe based on glucose levels, ketonemia, and acidosis (pH or bicarbonate). Not all criteria must be fulfilled to define a DKA as mild moderate or severe.

Speaker Profile

Dr. Prof. Mathieu Jozwaik

Dr. Prof. Mathieu Jozwaik

Intensive Care Medicine University Hospital Center, France
Dr. Prof. Mathieu Jozwaik is a distinguished specialist in Intensive Care Medicine at the University Hospital Center, France. With extensive expertise in managing critically ill patients, he is recognized for his contributions to advanced intensive care practices and for bringing clinical excellence and innovation to critical care delivery in France.

Assimilate | Management of Diabetic Keto-Acidosis in Critically ill Patients